ArticleFrontiers in immunology2024

Case report: A rare immune-related adverse effect: hepatic cavernous hemangioma induced by camrelizumab.

Chuantao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.